Steven Mintz Age X Therapeutics, Inc. (AGE) insider trading activity
Steven Mintz is Director of AgeX Therapeutics, Inc.. Currently has a direct ownership of 12,257 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Aug 15, 2024, when has been sold 1,350 shares (Common Stock) at a price of $6.59 per share, resulting in proceeds of $8,896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.3K
12.38%
3M change
n/a
12M change
Total Value Held
$0
STEVEN MINTZ Transaction History
SM
Steven Mintz
Director
Huntsville, AL